Why U.S. Business Deals Are Unlikely to Get Putin to Give Any Ground

While pharma peers stumble, AbbVie defeated the patent cliff

Investing.com · News 12m ago

Citizens raises Via Transportation stock price target on strong quarterly results

Investing.com · News 13m ago

Citizens reiterates Bicara Therapeutics stock rating on trial progress

Investing.com · News 13m ago

Aura Biosciences stock rating maintained at outperform by Citizens

Investing.com · News 13m ago

K+S Q3 2026 slides: revenue rises 6% as costs weigh on profit

Investing.com · News 15m ago

Earnings call transcript: Infineon lifts outlook on record Q4, stock jumps 9.05% | Q4 2026

Investing.com · News 15m ago

Michael Hartnett’s DEM Fatale: The AI Boom Meets Its Political Reckoning

Investing.com · Overview 15m ago

Down from highs: Why GlobalFoundries is an essential chip play

Investing.com · News 17m ago

Earnings call transcript: Technotrans Q3 2026 margins improve as orders hit record

Investing.com · News 18m ago

Oil Extends Losses On Easing Middle East Tensions

NASDAQ · Commodities 22m ago